Loading clinical trials...
Loading clinical trials...
The purpose of the study is to measure the effect of the amlodipine/atorvastatin combination pill in reducing both elevated blood pressure and cholesterol levels to levels suggested by guidelines
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
NCT06647511 · Gestational Hypertension
NCT07439939 · Liver Cirrhosis, Portal Hypertension
NCT05746039 · Obesity, Interstitial Lung Disease, and more
NCT07218029 · Pulmonary Arterial Hypertension
NCT07098065 · Tobacco Cessation, Health Warning Label, and more
Pfizer Investigational Site
Buenos Aires
Pfizer Investigational Site
Buenos Aires
Pfizer Investigational Site
Buenos Aires
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions